The story of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in income, its intellectual property lapse created a wave of generic competition , significantly impacting its position . While some firms may seek to capitalize on male sexual dysfunction, the existing